IMPORTANCE Tobacco use disorder is associated with dysregulated neurocognitive function in the right inferior frontal gyrus (IFG)-one node in a corticothalamic inhibitory control (IC) network.
modulating the strength of the presupplementary motor area's excitatory action on the subthalamic nucleus, in turn inhibiting motor output during IC. 5 Compared with nonsmokers, smokers exhibit less graymatter volume (GMV) in the corticothalamic pathway, including the IFG 7-9 and thalamus, 10,11 and greater functional magnetic resonance imaging (fMRI) blood oxygenation leveldependent (BOLD) response in the right IFG during neurocognitive tasks. 12, 13 Acute smoking abstinence further increases BOLD response in right IFG during IC 14 and other neurocognitive tasks. 13, 15, 16 Abnormalities in IFG structure and function implicate a compensatory mechanism by which smokers "overrecruit" the right IFG in an attempt to exert IC. These contrasting patterns of neural structure and function between smokers and nonsmokers may underlie differences in cognitive functioning 12, 17, 18 and impulsivity, 19 as well as withdrawalinduced cognitive disturbances in smokers; however, the effect of these neurophysiological disparities on inhibiting smoking behavior remains unknown. Across 2 studies, we measured baseline GMV and fMRI BOLD response during a well-validated measure of IC 20 to examine structural and functional correlates of the ability to resist smoking in adult daily smokers ( Table 1 and Table 2 ). In study 1 (cessation study), 81 participants underwent a baseline fMRI session 1 month before a quit attempt, and smoking behavior was assessed during a 10-week postquit period. In a separate sample of smokers (study 2, laboratory study), 26 participants first completed an fMRI visit and then performed a smoking relapse analog task (SRT). We hypothesized that less GMV and greater IC task-related BOLD response in corticothalamic circuitry would be associated with smoking relapse (study 1), as well as ad lib smoking during the SRT (study 2).
Methods

Participants and Procedures
Across Studies Inclusion criteria were being in good health, right-handed, aged 18 to 55 years, and smoking 10 cigarettes or more per day. Exclusion criteria were significant health problems, contraindications for MRI, use of psychoactive medications, use of smokeless tobacco or nicotine replacement therapy, current drug or alcohol abuse, afternoon expired carbon monoxide level less than 10 ppm (Vitalograph Inc), and positive urine illicit drug screen, breath alcohol level (Alert breathalyzer; Columbia Laboratory Supplies), or urine pregnancy test.
Key Points
Question What is the association between corticothalamicmediated inhibitory control and smoking relapse vulnerability?
Findings In 2 functional magnetic resonance imaging studies, a smoking cessation study (n = 81) and a laboratory-based smoking assessment (n = 26), corticothalamic circuitry function during inhibitory control was associated with smoking relapse vulnerability.
Meaning Findings that baseline differences in corticothalamic circuitry function mediate inhibitory control and smoking relapse vulnerability warrant further examination of interventions for augmenting corticothalamic neurotransmission during the course of tobacco use disorder treatment. 
Study 1
Smokers (n = 95) in the smoking cessation study (conducted at Duke University from 2008 to 2012) who were interested in quitting smoking were recruited via newspaper and internet advertisements. Participants underwent fMRI scanning 30 minutes after smoking a cigarette, were randomized to an experimental cessation treatment for 30 days before a quit attempt, and then returned to the laboratory to report their smoking behavior at 1, 3, 6, and 10 weeks after quitting (eMethods in the Supplement). Daily diaries of cigarette use, as well as levels of expired carbon monoxide, were collected at each visit to confirm abstinence (carbon monoxide level <8 ppm) or relapse. The primary smoking-cessation outcome variable was relapse defined as 7 consecutive days of smoking at least 1 cigarette per day. 21, 22 Following the baseline prequit fMRI scan, data from 14 participants were excluded from analyses: 8 withdrew before initiating a quit attempt, 3 for image artifacts, and 3 for incomplete imaging data, resulting in a final sample of 81 smokers (Table 1) . Forty participants either met criteria for relapse or were lost to contact and were grouped as relapsed. Forty-one participants who did not meet the relapse criterion were grouped as abstinent. To promote truthful reports, participation and payment were not contingent upon abstinence.
Study 2
Smokers (n = 30) in the laboratory study (conducted at the Medical University of South Carolina from 2013 to 2016) were recruited via newspaper and internet advertisements and expressed no interest in quitting smoking. Participants underwent fMRI scanning twice: once 30 minutes after smoking a cigarette (sated) and once following 24 hours of abstinence (order randomized). To replicate study 1 methods, all study 2 data reported herein are from the sated condition. Immediately following scanning, participants performed a smoking relapse analog task (SRT). During the SRT, participants were presented with positive, negative, and neutral emotional images on a computer screen over 6-minute time blocks while also being provided with an open pack of their preferred brand of cigarettes, ashtray, and lighter. Participants received $1 for each 6-minute block that they did not smoke, up to 10 blocks over a 1-hour period. Following the first block, participants could stop the task and forfeit earning money to smoke 1 cigarette. Latency to initiate ad lib smoking was recorded and smoking topography (puff count and volume) was measured using the Clinical Research Support System. eTable 1 in the Supplement provides the SRT performance results. Four participants were excluded due to poor IC task accuracy (<75% Go trials correct, as described below). The final sample was 26 participants (Table 2) . Across studies, all participants completed a training session during which they practiced the IC task and completed a smoking-history questionnaire and the Fagerström Test of Nicotine Dependence (FTND); FTND scores ranged between 1 (low) and 9 (high). 23 In addition, the participants were familiarized with the scanning environment using a mock MRI scanner.
Image Acquisition 
IC Task
The validated, fixed-jittered, event-related IC task 20 included randomly presented colored circles of 3 types of trial: frequent gray (Go, 75.4%; n = 388), rare yellow (RareGo, 12.3%; n = 65), and rare blue (NoGo, 12.3%; n = 65) (eFigure 1 in the Supplement). Participants were instructed to press a button with their right index finger as quickly as possible following each Go and RareGo trial; and to refrain from pressing in response to a NoGo trial.
Image Processing
Voxel-Based Morphometry Data Processing Structural images (study 1: n = 41 abstinent, n = 40 relapsed; study 2: n = 26) were preprocessed using the voxel-based morphometry 8 (VBM8) toolbox (http://dbm.neuro.uni-jena.de /vbm8) and statistical parametric mapping 12 (SPM12) (http: //www.fil.ion.ucl.ac.uk/spm) according to a standard pipeline. 
Statistical Analysis
General Statistical Considerations For both studies, significance was defined at α = .05, with a cluster-determining threshold of P < .001, as determined by Monte Carlo simulations individually for each statistical parametric mapping SPM model (3dClustSim; https://afni.nimh .nih.gov/pub/dist/doc/program_help/3dClustSim.html, May 2016). Specifically, 3dcalc was used to take the square root of the SPM model's error variance image (ResMS) and 3dFWHMx was used to empirically determine the spatial smoothness of residual error in the model using the newly developed nonGaussian autocorrelation function. Data from the National Institutes of Health, replicating the Beijing data sets, 26 show that these settings, combined with a cluster-determining threshold of P < .001 and a 10-mm 3 smoothing kernel, maintain a true false-positive rate of 5% for regular event-related designs. 27 The required cluster extent (cubic millimeters) for each model is noted in the respective table footnotes. Due to nonstationarity in VBM data, we thresholded at P < .05 familywise error at the voxel level. When significant clusters were observed at this cluster-determining threshold, cluster-level familywise error P values and cluster extent threshold values are reported.
Covariates
In study 1, differences in demographic characteristics and baseline self-report measures between the two groups (abstinent, relapsed) were analyzed with χ 2 and independent-sample, 2-tailed t tests (Table 1 ). Significant group differences were observed for nicotine dependence (FTND) and cigarettes per day. Cigarettes per day and FTND were positively correlated (r = 0.58; P < .001). The FTND results were associated with BOLD response in a priori ROIs, including presupplementary motor area (P = .004), right IFG (P = .03), and thalamus (P = .02), and was therefore included as a nuisance covariate in all models. Before hypothesis testing in study 1, we assessed whether the scanner used was a confound in the GMV or BOLD signal. A main effect of the scanner was observed in GMV (eTable 4 in the Supplement) and therefore was included as a covariate. No effect of the scanner was observed in the fMRI data or in the task-based functional connectivity (tbFC) ROI-ROI analysis (all P > .01). Visit order was included as a covariate in all study 2 models. Age, sex, and educational level are known confounds for morphometric analyses and thus were included as nuisance covariates in both studies. Functional connectivity is known to be particularly sensitive to rapid motion; therefore, the total number of interpolated volumes from motion-outlier detection was covaried at the second level in both studies.
Voxel-Based Morphometry
The VBM data were modeled at the second level in SPM12 using analysis of covariance for study 1 and time to smoke on the SRT in a regression analysis for study 2. For VBM analytic strategy, see the eMethods in the Supplement.
Experimental IC Task
Session data were entered into a first-level analysis using the general linear model 25 to examine the BOLD response to each of 5 trial types: NoGo correct , NoGo incorrect , RareGo correct , RareGo incorrect , and Go incorrect . Each event was modeled as a delta regressor at the onset of the event and convolved with a canonical hemodynamic response function. Intrarun motion was removed through rigid body rotation and translation and parameters were included as covariates. A high-pass filter (0.008 Hz) was applied to remove slow signal drift. Finally, to examine successful IC-BOLD response, controlling for novelty detection, a NoGo correct -RareGo correct contrast image was generated (henceforth, IC-BOLD) and used for hypothesis testing. Within-and between-participants (study 2 only) main effects of trial type on accuracy, within-participants main effects of rare trial type on BOLD response, and betweenparticipants main effects of group (study 1 only) on IC-BOLD response were each assessed via analysis of covariance. Next, the functional ROIs obtained from study 1 (right IFG and right thalamus) were used to obtain mean percent signal change from first-level models during IC (via MarsBaR). The main effect of task on BOLD response is shown in eFigure 3 and eTable 5 in the Supplement.
Task-Based Functional Connectivity
Corticothalamic tbFC was assessed at the second level based on first-level, voxelwise, Fisher-transformed correlationcoefficient maps. 28 In study 1, tbFC between right IFG and right thalamus functional ROIs from the IC-BOLD analysis was assessed using the conn14 ROI-ROI explorer (via betweenparticipant analysis of covariance). In study 2, a second-level seed-voxel strategy was implemented, seeding the right IFG functional ROI from study 1 to examine tbFC within a right thalamus automated anatomical labeling mask, and regression was performed to examine corticothalamic tbFC as a function of time to smoke on the SRT.
Mediation Path and Post hoc Analysis
Mediation analyses were performed to test the a priori hypothesis that corticothalamic tbFC during IC mediates the association between IC accuracy and smoking outcomes, using bootstrapping (10 000) with bias-corrected and accelerated (BCa) 95% CI. 29 Associations between GMV, BOLD, and tbFC findings, as well as with behavioral measures, were assessed (eMethods in the Supplement).
Results
Inhibitory Control Task
In study 1, inhibitory control task performance did not differ between the abstinent and relapsed groups (eFigure 4A and eTable 6A in the Supplement). A significant main effect of group demonstrated that, compared with those who remained abstinent, smokers who relapsed exhibited greater IC-BOLD responses in the right IFG (F 1,78 = 14.87) and right thalamus (F 1,78 = 14.97) (P <. 05) ( Figure 1A and eTable 3 in the Supplement). Furthermore, greater IC-BOLD response in the right IFG was associated with worse IC accuracy (β 78 = −0.234; R 2 = 0.037; P = .04), but not in the right thalamus (P = .47).
In study 2, successful IC accuracy predicted time to smoke during the SRT (eFigure 4B in the Supplement). Analogous to study 1, greater IC-BOLD response in the right IFG predicted a shorter time to smoke during the SRT (β = −0.468; P = .02; adjusted R 2 = 0.151) (t 23 = −2.49; β = −0.47; P = 0.02) ( Figure 1B and eTable 3 in the Supplement).
Corticothalamic tbFC
In study 1, stronger IC tbFC between the right IFG and thalamus (henceforth, corticothalamic) predicted successfully maintaining abstinence (F 1,77 =5 . 8 7 ;P =. 0 2 )( Figure 2A and eTable 7 in the Supplement) and IC accuracy (β 77 = 0.229; R 2 = 0.03; P = .04). In study 2, stronger IC tbFC in the corticothalamic circuit predicted a longer time to initiate smoking on the SRT (t 22 = 5.62; β = 0.79; P < .001, adjusted R 2 = 0.538) ( Figure 2B and eTable 7 in the Supplement) and greater IC accuracy (β 22 = 0.530; R 2 = 0.249; P = .009).
Mediation Path Analysis
Corticothalamic tbFC mediated the association between IC accuracy and smoking relapse outcomes in study 1 (β i = −0.0078; BCa 95% CI, −0.022 to −0.0002) ( Figure 3 and eTable 8A in the Supplement). In study 2, corticothalamic tbFC mediated the association between IC accuracy and time to smoke on the SRT, accounting for 51.7% of the A, In study 1 (cessation study), abstinent smokers exhibited less baseline (ie, prequit attempt) IC task-related BOLD response in the right inferior frontal gyrus (IFG) (yellow cluster in top figure) and right thalamus (yellow cluster in bottom figure) than did smokers who relapsed (P<.001 cluster-determining threshold, cluster extent >186 mm 3 ; 3dClustSim autocorrelation function) (eTable 3 in the Supplement). Error bars represent 1 SE. B, In study 2 (laboratory study), greater BOLD response in the right IFG during IC predicted a shorter time to smoke during the smoking relapse analog task (SRT) (β = −0.468; P = .02; adjusted R 2 = 0.151) (eTable 3 in the Supplement). All imaging data were analyzed within an IC network mask (eFigure 2 in the Supplement).
Association Between Corticothalamic Inhibitory Control and Smoking Relapse
Original 
Gray-Matter Volume
In study 1, compared with those who remained abstinent, smokers who relapsed exhibited significantly lower baseline GMV in the right IFG (F 1,74 = 28.32; familywise error P threshold = 0.03; a 1.7% difference) (eFigure 5 and eTable 9 in the Supplement). Gray matter volume was not associated with IC accuracy. No significant associations between SRT and GMV were found in study 2.
Post hoc Analyses
Post hoc analysis findings evaluating associations between VBM, BOLD response, and behavior are presented in eResults in the Supplement. In study 1, the right IFG BOLD response during IC was found to be negatively associated with right IFG GMV (r 74 = −0.353, P = .002). In study 2, semipartial correlation revealed a moderate negative association between IC taskrelated corticothalamic BOLD response and tbFC (r 22 = −0.434, P = .03).
Discussion
These studies reveal that IC task-related BOLD response in the right IFG and corticothalamic tbFC are associated with the ability to resist smoking; also, right IFG GMV was associated with maintaining abstinence. Moreover, corticothalamic tbFC mediated the association between IC task accuracy and both smoking relapse and time to lapse. To our knowledge, these are the first studies to directly link corticothalamic-mediated IC to the ability to resist smoking. The right IFG plays an important role in attentional control processes, including novelty detection, 30 sustained attention, 31 emotion-cognition interactions, 32 and resolving emotional distraction during goal-directed processes.
33-35
Smoking is an overlearned, prepotent response and smoking abstinence requires suppressing this response. Prior work has demonstrated that smoking abstinence disrupts the right IFG BOLD response during a broad array of neurocognitive tasks. [13] [14] [15] [16] However, previous studies did not report on whether the effects of acute abstinence on A, In study 1 (cessation study), smokers who remained abstinent exhibited stronger baseline corticothalamic tbFC during IC than smokers who relapsed at baseline (ie, prequit attempt) (P = .02) (eTable 7intheSupplement). Error bars represent 1 SE. B, In study 2 (laboratory study), stronger corticothalamic tbFC during inhibitory control predicted a longer time to initiate smoking on the smoking relapse analog task (SRT) (β=0.791;P < .001, adjusted R 2 = 0.538) (eTable 7 in the Supplement).
Research Original Investigation
Association Between Corticothalamic Inhibitory Control and Smoking Relapse frontally mediated neurocognition predicted inhibiting subsequent smoking behavior. In addition to the effect in the right IFG, we found that increased activity in the right thalamus, along with weaker tbFC between the IFG and thalamus, is associated with smoking lapse and relapse. 
Conclusions
Findings from the present studies provide new insight into associations between corticothalamic-mediated IC and tobacco use disorder and suggest value in assessing the efficacy of novel treatments for IC deficits that undergird the maintenance of cigarette smoking. Prior to randomization, all participants were fMRI scanned 30-min after smoking a cigarette. Participants were randomized (1:1) to two treatment conditions testing an experimental, pre-quit cessation treatment for the 30 days prior to the quit date. During these 30 days, participants were instructed to either continue smoking a typical number of their usual-brand cigarettes, or to smoke an equivalent number of very-low nicotine cigarettes (< 0.05 mg/cigarette; Quest brand, Vector Tobacco Co.) and wear a standard 21-mg nicotine replacement skin patch (Nicoderm CQ®, GlaxoSmithKline) every day. Following the 30-day pretreatment period, all participants quit smoking and were provided with standard NRT (21 mg/d for 6-weeks; 14 mg/d for 2-weeks, 7 mg/d for 2-weeks; Nicoderm CQ®, GlaxoSmithKline). Advice on quitting and minimal support were provided as requested by individual participants.
Study 1: Voxel-based Morphometry Analyses
VBM results were characterized in two ways: (1) for further statistical analyses, marginal mean GMV signal intensities were computed across significant clusters for analyses in SPSS; (2) unadjusted GMV signal intensities across significant clusters were converted to mean L/voxel by multiplying the mean voxel intensity value by voxel volume in order to characterize relative proportions of GMV per voxel 1 .
Multi-modal analyses
Due to the relatively small sample size in Study 2 compared to Study 1, all brain-behavioral statistics are bootstrapped using 5000 samples with bias-corrected and accelerated confidence intervals (BCa), although p-value is reported when significant where zero also falls outside of the 95% BCa. All coefficients reported are standardized, all R 2 values reported are adjusted if multiple predictor variables are in the model, and all tests are two-tailed unless otherwise mentioned. Homogeneity of covariance was assessed using Levene's or Box's test, and Mauchly's Test of Sphericity performed where applicable. Where violations were observed, Greenhouse-Geisser corrections and/or variance assumptions are reported.
eResults. Results of Post-Hoc Multi-Modal Analyses
Multi-modal analyses Study 1 (Cessation Study): Right IFG BOLD signal during IC was found to be negatively associated with right IFG GMV (r (74) = -0.353, P = .002), although there was no physical overlap between these clusters at our conservative threshold. No correlations between corticothalamic tbFC and BOLD signal or tbFC and GMV were observed; however, a hierarchical regression approach showed that while both increased corticothalamic tbFC (R 2 = 0.046) and decreased right IFG BOLD during IC (R 2 = 0.042) independently predicted IC accuracy, including both factors doubled the predictive ability of the model (R 2 = 0.081), indicating that each term largely predicts unique variance in IC accuracy. Post-hoc analyses: After controlling for FTND, cigs/day was significantly negatively correlated with corticothalamic tbFC (r (78) = -0.394, P < .001) and IC accuracy (r (78) = -.349, P = .002), but not BOLD response or GMV. No main effects of Treatment Group, or Outcome x Treatment Group interactions on any dependent variable were observed. Study 2 (Laboratory Study): Semi-partial correlation revealed a moderate negative association between corticothalamic BOLD response and tbFC during IC (r (22) = -0.434, P = .03). Brain findings were not associated with smoking topography (i.e. puff number and volume). See eTable 9 for SRT performance and topography results.
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